DE68914913D1 - Verfahren zur Herstellung von 2-Aminopurin. - Google Patents

Verfahren zur Herstellung von 2-Aminopurin.

Info

Publication number
DE68914913D1
DE68914913D1 DE68914913T DE68914913T DE68914913D1 DE 68914913 D1 DE68914913 D1 DE 68914913D1 DE 68914913 T DE68914913 T DE 68914913T DE 68914913 T DE68914913 T DE 68914913T DE 68914913 D1 DE68914913 D1 DE 68914913D1
Authority
DE
Germany
Prior art keywords
aminopurine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68914913T
Other languages
English (en)
Other versions
DE68914913T2 (de
Inventor
Peter Markham Kincey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE68914913D1 publication Critical patent/DE68914913D1/de
Publication of DE68914913T2 publication Critical patent/DE68914913T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE68914913T 1988-07-20 1989-07-18 Verfahren zur Herstellung von 2-Aminopurin. Expired - Lifetime DE68914913T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888817270A GB8817270D0 (en) 1988-07-20 1988-07-20 Novel process

Publications (2)

Publication Number Publication Date
DE68914913D1 true DE68914913D1 (de) 1994-06-01
DE68914913T2 DE68914913T2 (de) 1994-08-11

Family

ID=10640784

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68914913T Expired - Lifetime DE68914913T2 (de) 1988-07-20 1989-07-18 Verfahren zur Herstellung von 2-Aminopurin.

Country Status (7)

Country Link
US (1) US5066805A (de)
EP (1) EP0355986B1 (de)
JP (1) JP2825132B2 (de)
DE (1) DE68914913T2 (de)
ES (1) ES2053999T3 (de)
GB (1) GB8817270D0 (de)
PT (1) PT91205B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684153A (en) * 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
GB8822236D0 (en) * 1988-09-21 1988-10-26 Beecham Group Plc Chemical process
AT412211B (de) * 1996-07-20 2004-11-25 Novartis Int Pharm Ltd Verfahren zur herstellung von penciclovir und famciclovir
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9615275D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
AU2003268213A1 (en) * 2002-08-26 2004-03-11 Teva Pharmaceutical Industries Ltd. Crystalline solid famciclovir forms i, ii, iii and preparation thereof
EP1747223A1 (de) * 2004-05-18 2007-01-31 Teva Pharmaceutical Industries Ltd. Trocknungsverfahren zur herstellung von kristallinem festen famciclovir
US8143265B2 (en) 2007-04-16 2012-03-27 Meharry Medical College Method of treating atherosclerosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
EP0182024B1 (de) * 1984-09-20 1991-04-03 Beecham Group Plc Purin-Derivate und ihre pharmazeutische Verwendung
GB8507606D0 (en) * 1985-03-23 1985-05-01 Beecham Group Plc Process
US4965270A (en) * 1987-05-30 1990-10-23 Beecham Group P.L.C. Purine derivatives

Also Published As

Publication number Publication date
ES2053999T3 (es) 1994-08-01
PT91205B (pt) 1995-03-01
EP0355986A1 (de) 1990-02-28
US5066805A (en) 1991-11-19
JPH0273087A (ja) 1990-03-13
DE68914913T2 (de) 1994-08-11
GB8817270D0 (en) 1988-08-24
PT91205A (pt) 1990-02-08
JP2825132B2 (ja) 1998-11-18
EP0355986B1 (de) 1994-04-27

Similar Documents

Publication Publication Date Title
DE3852381T2 (de) Verfahren zur Herstellung von para-Ethylphenol.
DE3888647T2 (de) Verfahren zur Herstellung von Aminopropylsilanen.
DE3889595T2 (de) Verfahren zur Herstellung von Arylpiperidincarbinolen.
DE68913447T2 (de) Verfahren zur Herstellung von Halofluorbenzolen.
DE68914913T2 (de) Verfahren zur Herstellung von 2-Aminopurin.
DE3885262D1 (de) Verfahren zur Herstellung von 2-Chlor-5-methyl-pyridin.
DE3882167T2 (de) Verfahren zur Herstellung von Fluorbenzaldehyden.
DE68922714D1 (de) Verfahren zur Herstellung von 2-Phenylbenzotriazolen.
DE68920298D1 (de) Verfahren zur Herstellung von 4-Acetoxyazetidinonen.
DE3886877D1 (de) Verfahren zur Herstellung von Triphendioxazinen.
DE58905664D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.
DE58907097D1 (de) Verfahren zur Herstellung von 4-Chlorpyrazolen.
DE58905592D1 (de) Verfahren zur Herstellung von N-Hydroxypyrazolen.
DE3852408D1 (de) Verfahren zur Herstellung von Acyloxialkansulfonaten.
DE68919584D1 (de) Verfahren zur Herstellung von Chlorfluorbenzolen.
DE58909337D1 (de) Verfahren zur Herstellung von reinen 3-Butenyltriorganyloxysilanen.
DE3883919D1 (de) Verfahren zur Herstellung von o-Nitrophenetol.
DE59002525D1 (de) Verfahren zur Herstellung von 2-Chlor-4-nitro-alkylbenzol.
DE59005793D1 (de) Verfahren zur Herstellung von 2-Chlor-5-aminomethylpyridin.
DE68916375T2 (de) Verfahren zur Herstellung von 3-Iminonitrilen.
DE59006329D1 (de) Verfahren zur Herstellung von Phenyloxdiazolylanilinen.
DE59003539D1 (de) Verfahren zur Herstellung von Polychlor-fluor-cyclopentenen.
DE58907407D1 (de) Verfahren zur Herstellung von 1-Amino-2-brom-4-hydroxy-anthrachinon.
DE59006003D1 (de) Verfahren zur Herstellung von Epoxysulfonaten.
DE59005732D1 (de) Verfahren zur Herstellung von 3-Trichlormethyl-pyridin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD., HAMILT